India’s Pharma Exports Grow 9.4% in FY25, Target Double-Digit Expansion by 2026-27

India’s pharmaceutical exports stood at $30.47 billion in 2024-25, marking a 9.4% increase from the previous year, according to the commerce ministry. The rise was recorded across key product categories, including formulations and active pharmaceutical ingredients. 

As per the news reports, the industry has indicated that it is aiming for double-digit export growth in 2026-27. The sector is currently valued at about $60 billion and is projected to reach $130 billion by 2030. 

Concentration in Regulated Markets 

India exports medicines to over 200 countries and ranks third globally by volume. A substantial share of shipments is directed towards regulated markets that require strict quality and compliance standards. 

More than 60% of exports go to such markets. The United States accounted for 34% of total pharmaceutical exports in FY25, while Europe contributed 19%. 

Review at Chintan Shivir 

Export-related matters were discussed at a Chintan Shivir in Ahmedabad, attended by government officials and industry representatives. The meeting focused on trade procedures, compliance requirements and market access concerns. 

Participants were also briefed on developments in trade discussions with key partners. The European Union’s pharmaceuticals and medical devices market is estimated at $572.3 billion, and engagement with the bloc was reviewed in that context. 

Ongoing engagement 

A bilateral trade arrangement with the United States was discussed with reference to improving access and pricing conditions for Indian exporters. 

The commerce ministry said it will continue coordinating with exporters, regulators and Indian Missions abroad to identify and address issues affecting overseas shipments. With exports having crossed $30 billion in FY25, the industry is preparing to pursue higher growth over the next 2 financial years. 

Read More: Commerce Minister Piyush Goyal Launches 7 Measures Under ₹25,060 Crore Export Promotion Mission! 

Conclusion  

With exports at $30.47 billion in FY25, the sector has set a higher growth target for 2026-27. Policy discussions and trade engagements are expected to shape the next phase of expansion. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.   
 
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.